Most Recent Articles about Merck & Company
Generex: Establishing A Value For Antigen Express' Dividend Shares https://seekingalpha.com/article/4243546-generex-establishing-value-antigen-express-dividend-shares?source=feed_sector_healthcare Feb 23, 2019 - Generex will distribute 10% of its shares in Antigen Express on Monday, February 25, 2019.Immune Design accepted a $5.85 per share offer from Merck.Like Immune Design, Antigen Express is partnering wi
Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $7.7 million of Shares http://www.gurufocus.com/news/821392/merck--co-inc-mrk-chairman-president--ceo-kenneth-c-frazier-sold-77-million-of-shares Feb 23, 2019 - Merck & Co Inc (MRK) Chairman, President & CEO Kenneth C Frazier Sold $7.7 million of Shares, Stocks: MRK, release date:Feb 22, 2019
Merck to Buy Immunotherapy Developer Immune Design for $300M http://www.zacks.com/stock/news/356654/merck-to-buy-immunotherapy-developer-immune-design-for-%24300m?cid=CS-ZC-FT-356654 Feb 22, 2019 - Merck (MRK) plans to acquire Immune Design for $300 million in cash. Merck will pay $5.85 in cash for each share of Immune Design.

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals